Prior studies conducted in various populations, including in elderly individuals, kidney transplant recipients, and in patients with chronic heart failure, found that higher EPO levels are associated with an increased risk of death, even independent of hemoglobin levels [8–10]. The gene discussed is EPO; the disease is congestive heart failure.